Suppr超能文献

脓毒症与肠道微生物群的文献计量分析:2014年至2024年的趋势

Bibliometric analysis of sepsis and gut microbiota: Trends from 2014 to 2024.

作者信息

Zhang Runze, Huo Chenxing, He Chenming, Luo Jielian, Shan Yunan, Lu Jiamin, Zhang Jirong, Zhang Wen, Fang Bangjiang

机构信息

Department of Emergency, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Wuhan, China.

School of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China.

出版信息

Front Microbiol. 2025 Jun 19;16:1598443. doi: 10.3389/fmicb.2025.1598443. eCollection 2025.

Abstract

BACKGROUND

Sepsis is a life-threatening condition characterized by organ dysfunction resulting from a dysregulated host response to infection, with pathological mechanisms closely linked to imbalances in the intestinal flora. While the gut microbiota influences sepsis progression through metabolic and immune regulation, systematic analyses of research trends remain limited. This bibliometric study comprehensively evaluates the sepsis and gut microbiota field from 2014 to 2024.

METHODS

We analyzed 944 English-language articles from the Web of Science (WOS) Core Collection using CiteSpace, VOSviewer, and other software tools. The bibliometric assessments included analysis of publication trends, collaborative networks, geographic distributions, journal impact, and keyword clustering.

RESULTS

A total of 944 publications included contributions from 5,901 authors across 69 countries. These works were published in 405 journals, and cited a total of 45,932 references. The focus of research has transitioned from early topics such as "necrotizing enterocolitis" and "premature infants" to more recent interests on "short-chain fatty acids" (SCFAs) and "." Futhermore, emerging topics include "sepsis-associated encephalopathy," with microbiology and critical care medicine identified as interdisciplinary core fields.

CONCLUSION

The therapeutic potential of the gut microbiota in sepsis is increasingly recognized. Future research should prioritize microbial-targeted therapies, immune-barrier-metabolic network regulation, and integrated traditional Chinese-Western medicine approaches.

摘要

背景

脓毒症是一种危及生命的病症,其特征是宿主对感染的反应失调导致器官功能障碍,病理机制与肠道菌群失衡密切相关。虽然肠道微生物群通过代谢和免疫调节影响脓毒症的进展,但对研究趋势的系统分析仍然有限。这项文献计量学研究全面评估了2014年至2024年脓毒症和肠道微生物群领域的情况。

方法

我们使用CiteSpace、VOSviewer和其他软件工具分析了来自科学网(WOS)核心合集的944篇英文文章。文献计量评估包括对出版趋势、合作网络、地理分布、期刊影响力和关键词聚类的分析。

结果

共有944篇出版物,来自69个国家的5901名作者做出了贡献。这些作品发表在405种期刊上,共引用了45932篇参考文献。研究重点已从早期的“坏死性小肠结肠炎”和“早产儿”等主题转向最近对“短链脂肪酸”(SCFAs)和“.”的关注。此外,新兴主题包括“脓毒症相关性脑病”,微生物学和重症医学被确定为跨学科核心领域。

结论

肠道微生物群在脓毒症中的治疗潜力越来越受到认可。未来的研究应优先考虑针对微生物的疗法、免疫-屏障-代谢网络调节以及中西医结合方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f1c/12225644/3d9ca2905224/fmicb-16-1598443-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验